Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition.

BACKGROUND Obesity is associated with major changes in the circulating IGF system. However, it is not clear to what extent the IGF system is normalized following diet, and the possible role of different types of diet is also unknown. OBJECTIVE To compare changes in the circulating IGF system following 12 weeks of moderate energy restriction (7000 kJ/day) in overweight or obese males on a high protein high red meat diet (HP) or a high carbohydrate diet (HC). DESIGN Seventy-six men (mean age, 51+/-1.0 years; body mass index, 32.8+/-0.5 kg/m(2)) were allocated to matched groups treated with isocaloric diets of HP (n=34) or HC (n=42). Outcome measures were weight, body composition, IGF-related peptides, homoeostasis model assessment of insulin resistance (HOMA1-IR) and adipokines. RESULTS Weight loss did not differ between diets (HP 8.5+/-0.6 kg; HC 8.2+/-0.6 kg, P>0.05). IGF-related peptides increased total IGF1 (HP 23%; HC 18%, P<0.0001), bioactive IGF1 (HP 18%; HC 15%, P<0.002), IGF1:IGF-binding protein-3 (IGFBP-3; HP 29%; HC 22%, P<0.0001) and IGFBP-1 (HP 24%; HC 25%, P<0.01). By contrast, decreases were observed in IGFBP-3 (HP -4%; HC -3%, P<0.01), pro-IGF2 (HP -3%; HC -6%, P=0.001), total IGF2 (HP -7%; HC -3%, P=0.001) and sIGF2R (HP -10%; HC -6%, P<0.005). Only IGFBP-2 increased differentially by diet (HP 34%; HC 50%, P<0.0001, diet P<0.05). Adiponectin increased in both diets, but leptin and HOMA-IR decreased (P<0.001). CONCLUSIONS Weight loss induced by moderate energy restriction modulated the IGF system independent of dietary protein or red meat content. The effect of diet on IGFBP-2 appeared to have limited biological effect as total IGF2 and pro-IGF2 did not change.

[1]  R. Casamitjana,et al.  The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[2]  W. Ricart,et al.  No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance. , 2001, Obesity research.

[3]  D. Le Roith,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997 .

[4]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[5]  K. Brismar,et al.  Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  S. Larsson,et al.  Association of diet with serum insulin-like growth factor I in middle-aged and elderly men. , 2005, The American journal of clinical nutrition.

[7]  P. Cohen,et al.  Control of aging and longevity by IGF-I signaling , 2005, Experimental Gerontology.

[8]  P. Havel.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin , 2002, Current opinion in lipidology.

[9]  A. Juul,et al.  Effect of Weight Loss on Free Insulin‐Like Growth Factor‐I in Obese Women With Hyposomatotropism , 2007, Obesity.

[10]  J. Frystyk,et al.  Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  J. Cuzick,et al.  Increase in Serum Total IGF-I and Maintenance of Free IGF-I Following Intentional Weight Loss in Pre-menopausal Women at Increased Risk of Breast Cancer , 2010 .

[12]  G. Brinkworth,et al.  Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. , 2006, American heart journal.

[13]  E. Rimm,et al.  Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  A. Juul,et al.  Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects. , 2006, European journal of endocrinology.

[15]  B. Bengtsson,et al.  The GH/IGF-1 Axis in Obesity: Physiological and Pathological Aspects. , 2006, Metabolic syndrome and related disorders.

[16]  M. Fenech,et al.  High protein-high red meat versus high carbohydrate weight loss diets do not differ in effect on genome stability and cell death in lymphocytes of overweight men. , 2009, Mutagenesis.

[17]  P. Meier,et al.  Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. , 1991, The American journal of physiology.

[18]  Michael Fenech,et al.  Weight loss in obese men is associated with increased telomere length and decreased abasic sites in rectal mucosa. , 2009, Rejuvenation research.

[19]  J. Frystyk,et al.  Residual β-Cell Function More than Glycemic Control Determines Abnormalities of the Insulin-Like Growth Factor System in Type 1 Diabetes , 2004 .

[20]  J. Frystyk,et al.  Pro- and mature IGF-II during diet-induced weight loss in obese subjects. , 2005, European journal of endocrinology.

[21]  S. Grundy,et al.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[22]  H. Orskov,et al.  Free insulin-like growth factors in human obesity. , 1995, Metabolism: clinical and experimental.

[23]  N. Skakkebaek,et al.  Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  R. Young,et al.  The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[25]  S. Klein,et al.  Long‐term effects of calorie or protein restriction on serum IGF‐1 and IGFBP‐3 concentration in humans , 2008, Aging cell.

[26]  H. Parving,et al.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications , 2005, Diabetologia.

[27]  C. Mantzoros,et al.  Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Meghan E. Everett,et al.  Moderate protein intake improves total and regional body composition and insulin sensitivity in overweight adults. , 2008, Metabolism: clinical and experimental.

[29]  H. Rasmussen,et al.  Effect of dietary protein supplements on calcium excretion in healthy older men and women. , 2004, The Journal of clinical endocrinology and metabolism.

[30]  M. Aickin,et al.  Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. , 1996, American journal of public health.

[31]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[32]  J. Weiss,et al.  Soluble insulin‐like growth factor II/mannose 6‐phosphate receptor inhibits DNA synthesis in insulin‐like growth factor II sensitive cells , 2000, Journal of cellular physiology.

[33]  M. Noakes,et al.  Can a food frequency questionnaire be used to capture dietary intake data in a 4 week clinical intervention trial? , 2004, Asia Pacific journal of clinical nutrition.

[34]  J. Frystyk,et al.  Bioactive insulin-like growth factor-I in obesity. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  N. Skakkebaek,et al.  Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. , 1995, The Journal of clinical endocrinology and metabolism.

[36]  K. Højlund,et al.  Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[37]  H. Orskov,et al.  Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. , 1995, Growth regulation.

[38]  Chi-Ling Chen,et al.  Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. , 2008, Journal of biomedical science.

[39]  L. Frohman,et al.  Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. , 1988, The Journal of clinical endocrinology and metabolism.

[40]  J. Frystyk,et al.  Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. , 2003, The Journal of clinical endocrinology and metabolism.

[41]  A. Renehan,et al.  Obesity and cancer risk: the role of the insulin–IGF axis , 2006, Trends in Endocrinology & Metabolism.

[42]  L. Murphy,et al.  Relationship between serum leptin and the insulin-like growth factor-I system in humans. , 1999, Metabolism: clinical and experimental.

[43]  H. Orskov,et al.  A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. , 2003, American journal of physiology. Endocrinology and metabolism.

[44]  Amanda J. Patterson,et al.  The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle‐aged women in a study of iron supplementation , 2000, Australian and New Zealand journal of public health.

[45]  F. Clavel-Chapelon,et al.  Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women , 2007, European Journal of Clinical Nutrition.